TipRanks
Akso Health Group Sponsored ADR (DE:8HX)
FRANKFURT:8HX
Germany Market
8HX
Akso Health Group Sponsored ADR
RESEARCH TOOLSreports

Akso Health Group Sponsored ADR (8HX) Ratios

0 Followers

Akso Health Group Sponsored ADR Ratios

DE:8HX's free cash flow for Q4 2026 was $-0.09. For the 2026 fiscal year, DE:8HX's free cash flow was decreased by $ and operating cash flow was $-0.38. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
 21.77 21.77 14.20 39.52 1.76
Quick Ratio
 21.74 21.74 14.18 39.46 1.62
Cash Ratio
 0.02 0.02 12.76 23.70 0.68
Solvency Ratio
 -10.60 -1.87 -8.41 -2.63 -0.12
Operating Cash Flow Ratio
 -1.86 -1.47 0.09 0.38 -0.28
Short-Term Operating Cash Flow Coverage
 -46.14 -36.49 0.00 0.00 0.00
Net Current Asset Value
$ 180.84M$ 180.84M$ 180.32M$ 138.42M$ 8.84M
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 <0.01 <0.01 0.00 0.00
Debt-to-Equity Ratio
 <0.01 <0.01 <0.01 0.00 0.00
Debt-to-Capital Ratio
 <0.01 <0.01 <0.01 0.00 0.00
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.05 1.05 1.08 1.03 2.34
Debt Service Coverage Ratio
 -41.61 1.03 0.00 0.00 0.00
Interest Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
 <0.01 <0.01 0.00 0.00 0.00
Interest Debt Per Share
 <0.01 <0.01 <0.01 0.00 0.00
Net Debt to EBITDA
 -0.10 -0.13 99.34 9.86 0.56
Profitability Margins
Gross Profit Margin
-3.93%-0.08%-1.91%5.06%9.63%
EBIT Margin
-34.88%-28.92%-26.55%-357.78%-108.23%
EBITDA Margin
-15.06%-11.77%-12.00%-357.78%-108.23%
Operating Profit Margin
-721.63%-28.92%-1125.37%-357.78%-108.23%
Pretax Profit Margin
-721.62%-149.69%-1125.14%-376.57%-99.13%
Net Profit Margin
-667.88%-134.99%-913.38%-391.78%-10.32%
Continuous Operations Profit Margin
-886.55%-135.31%-916.71%-377.61%-99.26%
Net Income Per EBT
92.55%90.18%81.18%104.04%10.41%
EBT Per EBIT
100.00%517.60%99.98%105.25%91.59%
Return on Assets (ROA)
-50.20%-9.85%-62.79%-6.66%-6.65%
Return on Equity (ROE)
-50.15%-10.32%-67.79%-6.84%-15.59%
Return on Capital Employed (ROCE)
-56.85%-2.21%-82.68%-6.24%-161.40%
Return on Invested Capital (ROIC)
-56.74%-1.99%-67.35%-6.24%-161.40%
Return on Tangible Assets
-50.22%-9.85%-68.78%-6.66%-6.65%
Earnings Yield
-17.56%-1.13%-40.12%-39.86%-50.26%
Efficiency Ratios
Receivables Turnover
 11.13 10.80 1.15 0.00 1.43
Payables Turnover
 0.00 0.00 0.00 0.00 0.00
Inventory Turnover
 74.02 69.17 79.16 11.99 7.06
Fixed Asset Turnover
 493.03 478.41 129.01 0.00 0.00
Asset Turnover
 0.08 0.07 0.07 0.02 0.64
Working Capital Turnover Ratio
 0.08 0.08 0.09 0.03 1.26
Cash Conversion Cycle
 37.73 39.08 323.12 30.45 307.14
Days of Sales Outstanding
 32.80 33.81 318.51 0.00 255.47
Days of Inventory Outstanding
 4.93 5.28 4.61 30.45 51.67
Days of Payables Outstanding
 0.00 0.00 0.00 0.00 0.00
Operating Cycle
 37.73 39.08 323.12 30.45 307.14
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.02 -0.02 <0.01 0.06 -0.43
Free Cash Flow Per Share
 -0.02 -0.26 <0.01 0.06 -0.43
CapEx Per Share
 <0.01 0.24 <0.01 0.00 0.00
Free Cash Flow to Operating Cash Flow
 1.00 14.73 0.87 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 -1.11K -0.07 7.62 0.00 0.00
Capital Expenditure Coverage Ratio
 -1.11K -0.07 7.62 0.00 0.00
Operating Cash Flow Coverage Ratio
 -43.06 -34.05 14.40 0.00 0.00
Operating Cash Flow to Sales Ratio
 -1.13 -0.92 0.08 0.56 -0.25
Free Cash Flow Yield
-2.53%-11.44%0.30%5.69%-120.24%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -2.84 -76.00 -2.46 -2.51 -1.99
Price-to-Sales (P/S) Ratio
 44.94 119.13 22.76 9.83 0.21
Price-to-Book (P/B) Ratio
 3.00 9.11 1.69 0.17 0.31
Price-to-Free Cash Flow (P/FCF) Ratio
 -39.56 -8.74 328.95 17.56 -0.83
Price-to-Operating Cash Flow Ratio
 -33.51 -128.82 285.78 17.56 -0.83
Price-to-Earnings Growth (PEG) Ratio
 -0.03 0.81 -0.37 >-0.01 0.02
Price-to-Fair Value
 3.00 9.11 1.69 0.17 0.31
Enterprise Value Multiple
 -298.48 -1.01K -90.38 7.11 0.37
Enterprise Value
 640.74M 1.65B 160.27M -61.45M -5.22M
EV to EBITDA
 -298.48 -1.01K -90.38 7.11 0.37
EV to Sales
 44.95 119.14 10.85 -25.45 -0.40
EV to Free Cash Flow
 -39.58 -8.74 156.71 -45.47 1.60
EV to Operating Cash Flow
 -39.61 -128.84 136.15 -45.47 1.60
Tangible Book Value Per Share
 0.25 0.25 0.63 6.65 1.16
Shareholders’ Equity Per Share
 0.25 0.25 0.70 6.65 1.14
Tax and Other Ratios
Effective Tax Rate
 -0.12 0.10 0.19 >-0.01 >-0.01
Revenue Per Share
 0.02 0.02 0.05 0.12 1.73
Net Income Per Share
 -0.13 -0.03 -0.47 -0.45 -0.18
Tax Burden
 0.93 0.90 0.81 1.04 0.10
Interest Burden
 20.69 5.18 42.38 1.05 0.92
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.52 0.29 0.25 3.56 1.18
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.17 0.68 >-0.01 -0.15 0.25
Currency in USD